Harmony Biosciences Holdings, Inc. (HRMY)

NASDAQ: HRMY · Real-Time Price · USD

38.50

-1.27 (-3.19%)

At close: Aug 13, 2026, 4:00 PM EDT

39.62

+1.12 (2.91%)

After-hours: Aug 13, 2026, 7:34 PM EDT

HRMY Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	959.9	868.45	714.73	582.02	437.86	305.44
Revenue Growth	24.25%	21.51%	22.80%	32.93%	43.35%	91.21%
Cost of Revenue	235.91	198.34	156.82	121.24	83.48	55.52
Gross Profit	723.99	670.11	557.92	460.79	354.37	249.92
Selling, General & Admin	272.47	272.05	221.27	192.69	163.3	132.03
Research & Development	220.87	189.59	145.83	76.06	70.89	30.37
Total Operating Expenses	493.34	461.64	367.09	268.76	234.19	162.39
Operating Income	230.65	208.47	190.83	192.03	120.19	87.53
Interest Income	24.41	21.92	18.54	14.73	3.13	0.22
Interest Expense	-13.47	-14.65	-17.5	-23.76	-18.8	-24.19
Other Non-Operating Income (Expense)	-0.39	-0.68	-0.07	-9.61	0.17	-26.15
Total Non-Operating Income (Expense)	10.55	6.6	0.98	-18.63	-15.5	-50.12
Pretax Income	241.2	215.06	191.8	173.4	104.69	37.43
Provision for Income Taxes	59.93	56.38	46.31	44.54	-76.78	2.83
Net Income	181.27	158.69	145.49	128.85	181.47	34.6
Net Income to Common	181.27	158.69	145.49	128.85	181.47	34.6
Net Income Growth	0.20%	9.07%	12.91%	-28.99%	424.52%	-
Shares Outstanding (Basic)	58	57	57	59	59	58
Shares Outstanding (Diluted)	59	59	58	60	61	59
Shares Change	0.72%	1.17%	-4.15%	-1.19%	3.19%	119.09%
EPS (Basic)	3.13	2.76	2.56	2.17	3.07	0.60
EPS (Diluted)	3.08	2.71	2.51	2.13	2.97	0.58
EPS Growth	-0.65%	7.97%	17.84%	-28.28%	412.07%	-
Free Cash Flow	354.9	347.89	218.67	219.08	144.29	98.26
Free Cash Flow Growth	37.17%	59.09%	-0.19%	51.82%	46.85%	-
Free Cash Flow Per Share	6.04	5.94	3.78	3.63	2.36	1.66
Gross Margin	75.42%	77.16%	78.06%	79.17%	80.93%	81.82%
Operating Margin	24.03%	24.00%	26.70%	32.99%	27.45%	28.66%
Profit Margin	18.88%	18.27%	20.36%	22.14%	41.44%	11.33%
FCF Margin	36.97%	40.06%	30.59%	37.64%	32.95%	32.17%
EBITDA	255.99	233.8	214.94	216.39	143.57	106.37
EBITDA Margin	26.67%	26.92%	30.07%	37.18%	32.79%	34.82%
EBIT	230.65	208.47	190.83	192.03	120.19	87.53
EBIT Margin	24.03%	24.00%	26.70%	32.99%	27.45%	28.66%
Effective Tax Rate	24.85%	26.21%	24.14%	25.69%	-73.35%	7.56%

SEC Filings: 10-K · 10-Q